Modeling loop backbone flexibility in receptor‐ligand docking simulations

The relevance of receptor conformational change during ligand binding is well documented for many pharmaceutically relevant receptors, but is still not fully accounted for in in silico docking methods. While there has been significant progress in treatment of receptor side chain flexibility sampling of backbone flexibility remains challenging because the conformational space expands dramatically and the scoring function must balance protein–protein and protein–ligand contributions. Here, we investigate an efficient multistage backbone reconstruction algorithm for large loop regions in the receptor and demonstrate that treatment of backbone receptor flexibility significantly improves binding mode prediction starting from apo structures and in cross docking simulations. For three different kinase receptors in which large flexible loops reconstruct upon ligand binding, we demonstrate that treatment of backbone flexibility results in accurate models of the complexes in simulations starting from the apo structure. At the example of the DFG‐motif in the p38 kinase, we also show how loop reconstruction can be used to model allosteric binding. Our approach thus paves the way to treat the complex process of receptor reconstruction upon ligand binding in docking simulations and may help to design new ligands with high specificity by exploitation of allosteric mechanisms. © 2012 Wiley Periodicals, Inc.

[1]  Martin Zacharias,et al.  Efficient inclusion of receptor flexibility in grid‐based protein–ligand docking* , 2011, J. Comput. Chem..

[2]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[3]  Michel F Sanner,et al.  FLIPDock: Docking flexible ligands into flexible receptors , 2007, Proteins.

[4]  Jeffrey Skolnick,et al.  Assessment of programs for ligand binding affinity prediction , 2008, J. Comput. Chem..

[5]  Egon L. Willighagen,et al.  The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..

[6]  B. X. Carlson,et al.  A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta(2) subunit affects allosteric sensitivity to GABA and anesthetics. , 2000, Molecular pharmacology.

[7]  Hongyi Zhou,et al.  What is a desirable statistical energy functions for proteins and how can it be obtained? , 2007, Cell Biochemistry and Biophysics.

[8]  Richard A Friesner,et al.  Prediction of Protein Loop Conformations using the AGBNP Implicit Solvent Model and Torsion Angle Sampling. , 2008, Journal of chemical theory and computation.

[9]  W. Wenzel,et al.  Comparison of stochastic optimization methods for receptor-ligand docking , 2002 .

[10]  Rafael Najmanovich,et al.  Side‐chain flexibility in proteins upon ligand binding , 2000, Proteins.

[11]  N. Go,et al.  Ring Closure and Local Conformational Deformations of Chain Molecules , 1970 .

[12]  Christopher W Murray,et al.  Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation. , 2005, Journal of medicinal chemistry.

[13]  J. Sebolt-Leopold,et al.  Targeting the mitogen-activated protein kinase cascade to treat cancer , 2004, Nature Reviews Cancer.

[14]  D. Faulds,et al.  Etanercept: a review of its use in rheumatoid arthritis. , 1999, Drugs.

[15]  R. Davis,et al.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.

[16]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[17]  J. Zheng,et al.  Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.

[18]  Bert L. de Groot,et al.  Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations , 2010, PLoS Comput. Biol..

[19]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Ruben Abagyan,et al.  A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE) , 2008, J. Comput. Aided Mol. Des..

[21]  Horst Kessler,et al.  Multiple N-methylation by a designed approach enhances receptor selectivity. , 2007, Journal of medicinal chemistry.

[22]  Christopher W. Murray,et al.  The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase , 1999, J. Comput. Aided Mol. Des..

[23]  Johan Åqvist,et al.  Ligand binding affinity prediction by linear interaction energy methods , 1998, J. Comput. Aided Mol. Des..

[24]  Spencer S Ericksen,et al.  Three amino acids in the D2 dopamine receptor regulate selective ligand function and affinity , 2009, Journal of neurochemistry.

[25]  Dan S. Tawfik,et al.  Structure and kinetics of a transient antibody binding intermediate reveal a kinetic discrimination mechanism in antigen recognition. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Bethan Hughes,et al.  2009 FDA drug approvals , 2010, Nature Reviews Drug Discovery.

[27]  R. Nussinov,et al.  How different are structurally flexible and rigid binding sites? Sequence and structural features discriminating proteins that do and do not undergo conformational change upon ligand binding. , 2007, Journal of molecular biology.

[28]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[29]  Themis Lazaridis,et al.  Contributions to the binding free energy of ligands to avidin and streptavidin , 2002, Proteins.

[30]  B Montgomery Pettitt,et al.  Fast Calculations of Electrostatic Solvation Free Energy from Reconstructed Solvent Density using proximal Radial Distribution Functions. , 2011, The journal of physical chemistry letters.

[31]  G. Klebe Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[32]  Guilherme Menegon Arantes,et al.  Flexibility and inhibitor binding in cdc25 phosphatases , 2010, Proteins.

[33]  P. Kollman,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .

[34]  S. Teague Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[35]  Wolfgang Wenzel,et al.  Increasing Diversity in In-silico Screening with Target Flexibility , 2005, CompLife.

[36]  R. Nussinov,et al.  Induced Fit, Conformational Selection and Independent Dynamic Segments: an Extended View of Binding Events Opinion , 2022 .

[37]  T. Weikl,et al.  Selected‐fit versus induced‐fit protein binding: Kinetic differences and mutational analysis , 2008, Proteins.

[38]  Wolfgang Wenzel,et al.  Accuracy of binding mode prediction with a cascadic stochastic tunneling method , 2007, Proteins.

[39]  J. Pouysségur,et al.  Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. , 2003, Progress in cell cycle research.

[40]  Gisbert Schneider,et al.  Structure-Based Virtual Screening of FGFR Inhibitors , 2012, BioDrugs.

[41]  David Baker,et al.  Protein-protein docking with backbone flexibility. , 2007, Journal of molecular biology.

[42]  Martin Zacharias,et al.  Syntheses and activities of backbone‐side chain cyclic octapeptide ligands with N‐functionalized phosphotyrosine for the N‐terminal SH2‐domain of the protein tyrosine phosphatase SHP‐1 , 2010, Journal of peptide science : an official publication of the European Peptide Society.

[43]  Jeffrey J. Gray,et al.  Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. , 2008, Journal of molecular biology.

[44]  John Kuriyan,et al.  A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.

[45]  Ruben Abagyan,et al.  Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..

[46]  Jyothi Subramanian,et al.  Modeling and Selection of Flexible Proteins for Structure‐Based Drug Design: Backbone and Side Chain Movements in p38 MAPK , 2008, ChemMedChem.

[47]  M. DePristo,et al.  Relation between native ensembles and experimental structures of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R Abagyan,et al.  Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.

[49]  Kai Zhu,et al.  Toward better refinement of comparative models: Predicting loops in inexact environments , 2008, Proteins.

[50]  Wolfgang Wenzel,et al.  Flexible side chain models improve enrichment rates in in silico screening. , 2008, Journal of medicinal chemistry.

[51]  N. Ben-Tal,et al.  The ConSurf‐HSSP database: The mapping of evolutionary conservation among homologs onto PDB structures , 2004, Proteins.

[52]  E. Jaeger,et al.  Docking: successes and challenges. , 2005, Current pharmaceutical design.

[53]  Barbara M. Bolten,et al.  Trends in development cycles , 2002, Nature Reviews Drug Discovery.

[54]  John C. Lee,et al.  p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. , 2001, Progress in medicinal chemistry.

[55]  W. Wenzel,et al.  Stochastic Tunneling Approach for Global Minimization of Complex Potential Energy Landscapes , 1999 .

[56]  Claudio N. Cavasotto,et al.  Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.

[57]  Aleksandr V. Smirnov,et al.  Watching a Protein as it Functions with 150-ps Time-Resolved X-ray Crystallography , 2003, Science.

[58]  Thomas M Frimurer,et al.  Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities. , 2003, Biophysical journal.

[59]  Markus Wagener,et al.  A flexible approach to induced fit docking. , 2007, Journal of medicinal chemistry.

[60]  T. Steinbrecher,et al.  Towards accurate free energy calculations in ligand protein-binding studies. , 2010, Current medicinal chemistry.

[61]  K. Dill,et al.  Predicting absolute ligand binding free energies to a simple model site. , 2007, Journal of molecular biology.

[62]  Wolfgang Wenzel,et al.  Receptor flexibility in small‐molecule docking calculations , 2011 .

[63]  R. Dror,et al.  A conserved protonation-dependent switch controls drug binding in the Abl kinase , 2009, Proceedings of the National Academy of Sciences.

[64]  J A McCammon,et al.  Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.

[65]  A. Leach,et al.  Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.

[66]  Iris Antes,et al.  DynaDock: A new molecular dynamics‐based algorithm for protein–peptide docking including receptor flexibility , 2010, Proteins.

[67]  Roger S Armen,et al.  An Evaluation of Explicit Receptor Flexibility in Molecular Docking Using Molecular Dynamics and Torsion Angle Molecular Dynamics. , 2009, Journal of chemical theory and computation.

[68]  György M. Keserü,et al.  Ensemble Docking into Flexible Active Sites. Critical Evaluation of FlexE against JNK-3 and beta-Secretase , 2006, J. Chem. Inf. Model..

[69]  Peter E Wright,et al.  Millisecond timescale fluctuations in dihydrofolate reductase are exquisitely sensitive to the bound ligands , 2010, Proceedings of the National Academy of Sciences.

[70]  A. Sali,et al.  Protein Structure Prediction and Structural Genomics , 2001, Science.

[71]  Taebo Sim,et al.  A general strategy for creating "inactive-conformation" abl inhibitors. , 2006, Chemistry & biology.

[72]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[73]  Christoph A. Sotriffer,et al.  The Challenge of Affinity Prediction: Scoring Functions for Structure‐Based Virtual Screening , 2011 .

[74]  M. Zacharias,et al.  Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. , 2008, Journal of medicinal chemistry.

[75]  Xiaoling Xie,et al.  Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. , 2007, Journal of medicinal chemistry.

[76]  Dariusz Plewczynski,et al.  Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database , 2011, J. Comput. Chem..

[77]  M L Teodoro,et al.  Conformational flexibility models for the receptor in structure based drug design. , 2003, Current pharmaceutical design.

[78]  Madhusudan,et al.  Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit. , 2004, Biochemistry.

[79]  Jens Meiler,et al.  ROSETTALIGAND: Protein–small molecule docking with full side‐chain flexibility , 2006, Proteins.

[80]  E. Coutsias,et al.  Sub-angstrom accuracy in protein loop reconstruction by robotics-inspired conformational sampling , 2009, Nature Methods.

[81]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[82]  Mark A. Wilson,et al.  Intrinsic motions along an enzymatic reaction trajectory , 2007, Nature.

[83]  Michael K. Gilson,et al.  Enhanced docking with the mining minima optimizer: Acceleration and side‐chain flexibility , 2002, J. Comput. Chem..

[84]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[85]  Djamal Bouzida,et al.  Complexity and simplicity of ligand-macromolecule interactions: the energy landscape perspective. , 2002, Current opinion in structural biology.

[86]  M. Lill Efficient incorporation of protein flexibility and dynamics into molecular docking simulations. , 2011, Biochemistry.

[87]  K. Smalley,et al.  A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? , 2003, International journal of cancer.

[88]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[89]  Gerhard Klebe,et al.  PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations , 2007, Nucleic Acids Res..

[90]  J. An,et al.  Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.

[91]  T. Langer,et al.  Charakterisierung der Dynamik der Kinase p38 in freiem und ligandgebundenem Zustand durch NMR‐Spektroskopie , 2006 .

[92]  D. Koshland Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Christopher I. Bayly,et al.  Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation , 2002, J. Comput. Chem..

[94]  R. Morphy Selectively nonselective kinase inhibition: striking the right balance. , 2010, Journal of medicinal chemistry.

[95]  R. Nussinov,et al.  The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.

[96]  Markus A Lill,et al.  Raptor: combining dual-shell representation, induced-fit simulation, and hydrophobicity scoring in receptor modeling: application toward the simulation of structurally diverse ligand sets. , 2004, Journal of medicinal chemistry.

[97]  J. McCubrey,et al.  Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). , 2003, International journal of oncology.

[98]  R M Stroud,et al.  Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking. , 2001, Chemistry & biology.

[99]  Harold A. Scheraga,et al.  Standard‐geometry chains fitted to X‐ray derived structures: Validation of the rigid‐geometry approximation. II. Systematic searches for short loops in proteins: Applications to bovine pancreatic ribonuclease A and human lysozyme , 1992 .

[100]  Jerry L. Adams,et al.  2,4,5- triarylimidazole inhibitors of IL-1 biosynthesis , 1995 .

[101]  Ian W. Davis,et al.  RosettaLigand docking with full ligand and receptor flexibility. , 2009, Journal of molecular biology.

[102]  T. Oas,et al.  Conformational selection or induced fit: A flux description of reaction mechanism , 2009, Proceedings of the National Academy of Sciences.

[103]  N L Carteron,et al.  Cytokines in rheumatoid arthritis: trials and tribulations. , 2000, Molecular medicine today.

[104]  Somesh D. Sharma,et al.  Managing protein flexibility in docking and its applications. , 2009, Drug discovery today.

[105]  D. Strumberg,et al.  The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer , 2002, Oncology Research and Treatment.

[106]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..